Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.

The Journal of rheumatology ·Vol. 35 ·No. 5 ·2008-05-00 ·Pages 936-8

Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T, Nara H, Iwamoto M, Yoshio T, Okazaki H, Minota S

Abstract

暂无摘要

MeSH Terms

Adiponectin/blood Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal/therapeutic use Antirheumatic Agents/therapeutic use Arthritis, Rheumatoid/blood,drug therapy,ethnology Etanercept Female Humans Immunoglobulin G/therapeutic use Infliximab Japan Male Middle Aged Receptors, Tumor Necrosis Factor/therapeutic use Regression Analysis Severity of Illness Index Sex Characteristics Tumor Necrosis Factor-alpha/antagonists & inhibitors

Chemicals

Adiponectin Antibodies, Monoclonal Antirheumatic Agents Immunoglobulin G Receptors, Tumor Necrosis Factor Tumor Necrosis Factor-alpha Infliximab Etanercept

Authors & Affiliations

11 authors, click to expand affiliations / ORCID

Nagashima Takao

Okubo-Fornbacher Hikaru

Aoki Yoko

Kamata Yasuyuki

Kimura Hirotaka

Kamimura Takeshi

Nara Hiroyuki

Iwamoto Masahiro

Yoshio Taku

Okazaki Hitoaki

Minota Seiji

Article Info

Journal

The Journal of rheumatology

Abbr.

J Rheumatol

ISSN

0315-162X

Published

2008-05-00

Pages

936-8

Language

English

Region

Canada

NLM ID

7501984

Subset

Corrections

CommentIn

PMID: 19509093

External Links

PubMed source View journal details

Analysis Services

Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.

Contact

WeChat Official Account